Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Patent
1990-09-18
1992-09-22
Cashion, Jr., Merrell C.
Drug, bio-affecting and body treating compositions
Lymphokine
Interleukin
514 2, A61K 3702
Patent
active
051495279
ABSTRACT:
Immunopotentiating compositions which are useful in causing tumor necrosis and/or regression in subjects who have previously received successful therapy which destroys tumors and stimulates cytotoxic macrophages are described. The immunopotentiators are administered at a time when formation of macrophages specifically cytotoxic for the tumor have been generated by previous therapy.
REFERENCES:
Fizames et al., J. Biol. Resp. Mod. Aug. 1989, 8(4) pp. 397-408 (Abstract).
Tokunaga, Ganto Kagaku Ryoho, May 1987 14 (5 pt 2) pp. 1358-1366 (Abstract).
Adler et al, J. Natl Cancer Inst. Feb. 1985, 74(2) pp. 429-436 (Abstract).
Immunological Mechanisms in Cancer Treatment Klippel et al (Abstract)-monograph pp. 79-158.
Coley, Am. J. Med. Sci. (1893) 103:487-511.
Coley, Trans. Am. Surg. Assoc. (1894) 12:183-212.
Oettgen et al., "Important Advances in Oncology" B. T. DeVita, Jr., et al., eds., J. B. Lippincott Company, Philadelphia, Pa. pp. 105-132.
Hersh, "Immunity to Cancer" A. E. Reif et al., Academic Press, Orlando, Fla. (1985) pp. 443-452.
Yamamoto et al., Cancer Res. (1987) 47:2008-2013.
Yamamoto et al., Cancer Res. (1988) 48:6044-6049.
Ruszala-Mallon et al., Int. J. Immunopharmacol. (1988) 10(5):497-510.
Cockett et al., Proc. Clin. Biol. Res. (1989) 303:455-462.
Mayer, New Eng. J. Med. (1990) 322(6):399-401.
Cashion Jr. Merrell C.
Koh Choon
Oncotech, Inc.
LandOfFree
Immunopotentiating protocol for chemotherapy-responsive tumors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immunopotentiating protocol for chemotherapy-responsive tumors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunopotentiating protocol for chemotherapy-responsive tumors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1067012